Orange County’s hub of diagnostics and testing firms saw employment drop for the second straight year as they restructured and their clients dealt with bouts of COVID-19 resurgence that limited testing.
Author summary Within 5 months, an emerging human monkeypox virus (MPXV) pandemic has caused >65,000 cases, leading the World Health Organization to declare it a public health emergency of international concern (PHEIC). Applying former United States Secretary of Defense Donald Rumsfeld’s idiom, we reflect upon the “known knowns,” “known unknowns,” and “unknown unknowns” to improve prevention and treatment for this and future pandemics.
Irvine, CA (PRWEB) May 12, 2022 Fluxergy has joined as an inaugural member of the Wyss Diagnostics Accelerator’s (Wyss DxA) Industrial Participant Program
CET- Comunicado - ;ultimaHoraHtml += + json.lead + ;}ultimaHoraHtml += ; document.getElementById( urgente ).innerHTML = ultimaHoraHtml; } } });
Fluxergy Announces Improved Clinical Performance of Its CE-IVD COVID-19 PCR Test - FLUXERGY
Irvine, Ca /11 de mayo de 2021.- News Aktuell
Fluxergy, Inc., a U.S. medical diagnostic point-of-care platform company with a detection technology solution capable of multiplexity and multimodality, is further announcing improved clinical performance of its CE-IVD COVID-19 RT-PCR test. The CE marking for its one-hour COVID-19 Test Kit allows healthcare professionals to use its
in vitro diagnostics (IVD) assay for the detection of SARS-CoV-2. Fluxergy’s innovative testing platform is approved for IVD use in the European Union market and any other markets that accept CE marking as valid regulatory approval.